Bromocriptine - from Parkinson's disease to diabetes?

Nissen, Lisa (2011) Bromocriptine - from Parkinson's disease to diabetes?. Australian Pharmacist, 30 4: 290-290.

Attached Files (Some files may be inaccessible until you login with your UQ eSpace credentials)
Name Description MIMEType Size Downloads
UQ253672_fulltext_other.pdf UQ253672_fulltext_other.pdf Click to show the corresponding preview/stream application/pdf 192.46KB 1
Author Nissen, Lisa
Title Bromocriptine - from Parkinson's disease to diabetes?
Journal name Australian Pharmacist   Check publisher's open access policy
ISSN 0728-4632
Publication date 2011
Sub-type Article (original research)
Volume 30
Issue 4
Start page 290
End page 290
Total pages 1
Place of publication Curtin, ACT, Australia
Publisher Pharmaceutical Society of Australia
Collection year 2012
Language eng
Abstract The benefits and advantages offered by the use of Bromocriptine in the treatment of non-insulin dependent diabetes mellitus (NIDDM) or type 2 diabetes as well as Parkinson's disease are discussed. Some of the commonly reported adverse events following treatment with the same are highlighted.
Q-Index Code CX
Q-Index Status Confirmed Code
Institutional Status UQ
Additional Notes Issue section: "Old drug new indication"

Document type: Journal Article
Sub-type: Article (original research)
Collections: HERDC Pre-Audit
Non HERDC
School of Pharmacy Publications
 
Versions
Version Filter Type
Citation counts: Google Scholar Search Google Scholar
Access Statistics: 55 Abstract Views, 2 File Downloads  -  Detailed Statistics
Created: Thu, 29 Sep 2011, 13:51:26 EST by Charna Kovacevic on behalf of School of Pharmacy